Home / For clinicians / Conditions / Hematology
Hematology
3 conditions and 4 prescribing guides so far.
By specialty and condition
Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials.
Prescribing guides
The first 90 days from the prescriber's side, built from the current label, the drugmaker's program and one public insurer policy.
Hemophilia A
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl (efanesoctocog alfa))Dosing, Inhibitors and PANo REMS and no boxed warning; prior authorization, HemAssist enrollment online or by fax, specialty pharmacy shipment and IV infusion training before the first home dose.Hemlibra (emicizumab-kxwh)Dosing, aPCC Warning and PANo REMS; specialty pharmacy, treatment center or hospital pharmacy dispensing after prior authorization; HEMLIBRA Access Solutions starts only once both the Prescriber Service Form and the Patient Consent Form are received.Immune thrombocytopenia (ITP)
Wayrilz (rilzabrutinib)Dosing, Liver Monitoring and PA CriteriaNo REMS; baseline bilirubin, transaminases and pregnancy status before the first dose; HemAssist enrollment online or by fax to 1-855-398-7634; prior authorization; HemAssist triages the prescription to the patient's specialty pharmacy.Paroxysmal nocturnal hemoglobinuria (PNH)
Empaveli (pegcetacoplan)REMS, Vaccines and PA CriteriaREMS-certified prescriber, pneumococcal and meningococcal (ACWY and B) vaccination at least 2 weeks before day 1 or antibacterial prophylaxis with vaccines as soon as possible, no unresolved encapsulated bacterial infection, counseling with the Patient Guide and Patient Safety Card, and the pharmacy's documentation of vaccination status with the office.